Skip to content

Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation

A Safety Study to Evaluate Intracranial Pressure With the Utilization of High Frequency Chest Wall Oscillation (HFCWO) Using the Vest™ on Mechanically Ventilated Neurosurgical Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00279097
Enrollment
20
Registered
2006-01-19
Start date
2006-01-31
Completion date
2006-09-30
Last updated
2006-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Pressure

Keywords

Intracranial pressure, High Frequency Chest Wall Oscillation, Neurosurgery

Brief summary

The purpose of this study is to evaluate changes in intracranial pressure (ICP) during or immediately following high frequency chest wall oscillation (HFCWO) treatment with the Vest™ in neurosurgical subjects.

Detailed description

This study is a single site safety study to evaluate changes in intracranial pressure during or immediately following HFCWO treatment with the Vest™ in neurosurgical subjects with intracranial pressure monitors having normal opening pressures and ICP less than or equal to 20 mmHg. The secondary objective of this study is to evaluate changes in arterial blood gases that may result with Vest™ therapy in ventilated patients.

Interventions

Sponsors

Hill-Rom
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ICP monitor with normal opening pressure (greater than or equal to 20 mmHg) * On ventilator * Arterial line in place * Age equal to or greater than 18 * Admitted to neurotrauma intensive care unit (ICU)

Exclusion criteria

* Inability to obtain informed consent * Unstable spinal cord injury * ICP \> 20 mmHg sustained for \> 5 minutes * Hemodynamic instability within the prior 12 hours * Active hemoptysis * Hemothorax * New onset, unstable arrhythmia * Enrollment in another interventional study * Aneurysm that has not been clipped or coiled * Coagulopathic head injury subjects

Design outcomes

Primary

MeasureTime frame
Intracranial pressure
SpO2
Heart rate
Mean arterial pressure (MAP)
Arterial blood gases (ABGs)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026